{"disease":{"id":"infections-rotavirus","name":"infections rotavirus"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00875641","title":"Safety Study of GSK Biologicals' Rotavirus Vaccine (Rotarix®) Administered to Children Aged <1 Year in the United States","phase":"","overall_status":"COMPLETED","enrollment_count":390659,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00140673","title":"A Study to Test 2 Doses of the HRV Vaccine in Healthy Infants.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":63227,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT07358910","title":"Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Institut Pasteur du Cambodge","has_results":false},{"nct_id":"NCT01733862","title":"Study to Assess the Impact of Vaccination on Hospitalizations and Outpatient Visits Due to Rotavirus Gastroenteritis","phase":"","overall_status":"COMPLETED","enrollment_count":5394,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT01171963","title":"Study to Assess the Efficacy, Immunogenicity and Safety of Liquid Human Rotavirus Vaccine, in Healthy Chinese Infants","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3340,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00750893","title":"Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix (Human Rotavirus Vaccine) in Infants","phase":"","overall_status":"COMPLETED","enrollment_count":3111,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00385320","title":"Evaluate Protective Efficacy of Diff Strengths of Human Rotavirus Vaccine After Admn of 2 Doses to Infants Aged 2 Months","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":2640,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT00420316","title":"Long-term Efficacy and Safety of Subjects Approximately 3 Years After Priming With 2 Doses of GSK Bio's HRV Vaccine.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1613,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT02914184","title":"Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1612,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00353366","title":"To Evaluate Safety & Reactogenicity of GSK Bio's Human Rotavirus (HRV) Vaccine in Filipino Infants at Least 6 Weeks of Age at First Vaccination","phase":"","overall_status":"COMPLETED","enrollment_count":1439,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT03954743","title":"Safety Study of 2 Formulations of GSK's Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1351,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00363545","title":"To Assess Immunogenicity, Reactogenicity & Safety of 2 Formulations of GSK's HRV Vaccine as 2-dose Vaccination (Infants)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1274,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00420745","title":"To Assess Safety, Reactogenicity & Immunogenicity of 2 Doses of GSK's Oral Human Rotavirus Vaccine in Pre-Term Infants","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1009,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00653198","title":"Effectiveness of Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants in Panama","phase":"","overall_status":"COMPLETED","enrollment_count":885,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT00480324","title":"Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese Infants","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":765,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00969228","title":"Study to Evaluate Immunogenicity, Reactogenicity and Safety of Rotarix™ Vaccine in Korean Infants","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":684,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01177826","title":"Effectiveness Study of GSK Biologicals' Rotarix TM Vaccine in Hospitalized Children","phase":"","overall_status":"COMPLETED","enrollment_count":643,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT00779779","title":"Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Infants","phase":"","overall_status":"COMPLETED","enrollment_count":522,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00432380","title":"A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":375,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00289172","title":"Assess the Immunogenicity & Safety of 2 Doses of Oral Live Attenuated Human Rota(HRV)Vaccine in Healthy Infants in India","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":360,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT00938327","title":"Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Indian Infants","phase":"","overall_status":"COMPLETED","enrollment_count":332,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00533507","title":"Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 8 Weeks of Age","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":230,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00396630","title":"A Study to Explore the Existence of Horizontal Transmission of the RIX4414 Vaccine Strain Between Twins Within a Family.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00263666","title":"A Study of Safety, Reactogenicity and Immunogenicity of HRV Vaccine in HIV Infected Infants in South Africa","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01162590","title":"Study to Evaluate the Reactogenicity and Safety of Rotarix™ in Chinese Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT01086436","title":"Study to Evaluate the Safety of Rotarix™ in Chinese Children","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT01107587","title":"Study to Assess the Safety of GSK Biologicals' Liquid Human Rotavirus Vaccine in Healthy Infants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT05037435","title":"Safety and Immunological Efficacy of the Pentavalent Rotavirus Vaccine - Rota-V-Aid™ (Live Attenuated Oral, Freeze-dried) at Healthy Adults Aged 18 to 45 Years.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Limited Liability Company Pharm Aid","has_results":false},{"nct_id":"NCT01198769","title":"Immunogenicity and Safety Study of Rotarix TM in Taiwanese Infants Who Received Hepatitis B Immunoglobulin After Birth.","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01563159","title":"Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2010-2011","phase":"","overall_status":"COMPLETED","enrollment_count":1,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT01563146","title":"Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2006-2007","phase":"","overall_status":"COMPLETED","enrollment_count":1,"lead_sponsor_name":"GlaxoSmithKline","has_results":false}],"total":31},"guidelines":[],"source":"Drug Landscape verified database"}